|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Fundació Sant Joan de Déu Carlos III Health Institute Catalan Institute of Health University of Barcelona (UB) |
|---|---|
| Information provided by: | Fundació Sant Joan de Déu |
| ClinicalTrials.gov Identifier: | NCT00794196 |
Purpose
The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.
| Condition | Intervention |
|---|---|
|
Depression Antidepressive Agents Primary Care |
Behavioral: Pharmaceutical care program for antidepressant treatment |
| Study Type: | Interventional |
| Study Design: | Supportive Care, Randomized, Double Blind (Investigator, Outcomes Assessor), Parallel Assignment, Efficacy Study |
| Official Title: | Impact of the Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care on the Compliance to Antidepressants and Patient Wellbeing |
| Estimated Enrollment: | 200 |
| Study Start Date: | October 2008 |
| Estimated Study Completion Date: | May 2010 |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Usual Care: No Intervention
The control group will be receiving usual medical and pharmaceutical care.
|
|
|
Intervention Group: Experimental
Intervention group will be receiving usual medical and pharmaceutical care plus a pharmaceutical support program.
|
Behavioral: Pharmaceutical care program for antidepressant treatment
The pharmaceutical care program is a support program for patients starting and maintaining antidepressant treatment.
|
The aim of this study is to evaluate the efficacy of a support program in community pharmacy on the improvement of the compliance to antidepressants and the clinic of typical primary care patients under normal practice circumstances. That implies that the intervention is made by pharmacists without any specific requirement that work in the community pharmacies set up in the area of study and on patients following the usual medical circuit. As well, the cost of the support program is calculated in order to set the effectiveness of the program.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Maria Rubio, Pharmacist | 0034 93 640 63 50 ext 2540 | mrubio@sjd-ssm.com |
| Spain, Barcelona | |
| Primary Care Center Gavà 1 | Recruiting |
| Gava, Barcelona, Spain, 08850 | |
| Contact: Eva Alonso, Doctor eva76@mixmail.com | |
| Principal Investigator: Eva Alonso, Doctor | |
| Primary Care Center Doctor Bartomeu Fabres Anglada | Recruiting |
| Gavà, Barcelona, Spain, 08850 | |
| Contact: Maite Peñarubia, Doctor 32829mpm@comb.es | |
| Principal Investigator: Maite Peñarubia, Doctor | |
| Sub-Investigator: Annabell Torres, Doctor | |
| Principal Investigator: | Antoni Serrano, MD PhD | Foundation Sant Joan de Deu |
More Information
| Responsible Party: | Foundation Sant Joan de Deu ( M.D., Ph.D., Antoni Serrano Blanco ) |
| Study ID Numbers: | FIS PI070546 |
| Study First Received: | November 17, 2008 |
| Last Updated: | November 17, 2008 |
| ClinicalTrials.gov Identifier: | NCT00794196 |
| Health Authority: | Spain: Ministry of Health and Consumption |
|
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |
